Skip to main content
. 2023 Mar 7;14:1095487. doi: 10.3389/fphar.2023.1095487

FIGURE 6.

FIGURE 6

Dapagliflozin inhibited the activation of TGF-β1/MAPK pathway in 0.2% adenine diet-fed mice. (A) Real time PCR showing the expression of TGF-β1 in the renal tissue of each group. (B, C) Western blot showing the expression of p-ERK and p-P38 in each group. Values are means ± SD. ***p < 0.001 adenine diet group compared with the control group; ## p < 0.01 dapagliflozin treatment group compared with the adenine diet group; ### p < 0.001 dapagliflozin treatment group compared with the adenine diet group.